FDA delays decision on Moderna vaccine for adolescents
The U.S. Food and Drug Administration requires more time to decide on whether to approve use of Moderna's two-dose COVID-19 vaccine on adolescents 12 to 17 years of age, the pharmaceutical company said.
from Latest News - UPI.com https://ift.tt/3pUC8l9
via IFTTT
from Latest News - UPI.com https://ift.tt/3pUC8l9
via IFTTT
Comments
Post a Comment